CHMP issues positive opinion for five new medicines and nine extensions

Palko begins work on Breyanzi recommendation

Sweden lacks a national adult vaccination program

NHTA collaborates with DTU Computerome for Nordic Real-world evidence studies

EFPIA: Invest early in health to save later

US MFN pricing could make Sweden a global price anchor

Denmark weighs allergy medicine reimbursement, with shifts for Grazax

NICE recommends zanidatamab for HER2-positive advanced biliary tract cancer

NICE backs Jaypirca in draft guidance for relapsed CLL

NICE recommends Blenrep for relapsed multiple myeloma